New frontiers in

From CRISPR to bispecifics, cancer to COPD,
new drugs on the cusp

Download the report

The miracle drugs of tomorrow

The Clarivate Drugs to Watch report spotlights recently-launched or soon-to-launch drugs with the potential to change treatment paradigms and/or reach blockbuster status within five years.

arrow_downwardDownload the report

Drugs to Watch in 2024

A dozen new and emerging therapeutics with the potential to transform treatment paradigms and/or become blockbusters within the next five years, according to Clarivate data and predictive analytics.

arrow_forwardSee the list


In identifying our 2024 Drugs to Watch, we drew on the expertise of more than 160 Clarivate analysts and 11 integrated data sets spanning hundreds of drugs, diseases and markets and covering the whole of the innovation lifecycle.

arrow_forwardMore on methodology


Key trends to watch

Critical developments in the global market for pharmaceuticals and biologics include the rise of AI and gene therapy, the impact of the Inflation Reduction Act, the maturation of biosimilars and the potential of real world data in therapeutics innovation.

arrow_forwardExplore trends

Resources & insights

From innovation to bottom line

Access global intelligence, advanced analytics and global experts from Clarivate.

Contact our team